These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 2884159

  • 41. Catecholamine responses and their interactions with other glucoregulatory hormones.
    Vranic M, Gauthier C, Bilinski D, Wasserman D, El Tayeb K, Hetenyi G, Lickley HL.
    Am J Physiol; 1984 Aug; 247(2 Pt 1):E145-56. PubMed ID: 6147092
    [Abstract] [Full Text] [Related]

  • 42. Prolonged infusion of somatostatin with glucagon replacement increases plasma glucose and glucose turnover in man.
    Ward WK, Best JD, Halter JB, Porte D.
    J Clin Endocrinol Metab; 1984 Mar; 58(3):449-53. PubMed ID: 6141177
    [Abstract] [Full Text] [Related]

  • 43. Relationship of glucagon suppression by insulin and somatostatin to the ambient glucose concentration.
    Starke A, Imamura T, Unger RH.
    J Clin Invest; 1987 Jan; 79(1):20-4. PubMed ID: 2878938
    [Abstract] [Full Text] [Related]

  • 44. Changes in glucagon do not play an essential role in the glucoregulatory responses to mild hyperinsulinemia in dogs.
    Werther GA, Banach W, Joffe S, Artal R, Sperling MA.
    Diabetes Res Clin Pract; 1987 Jan; 3(1):55-61. PubMed ID: 2880702
    [Abstract] [Full Text] [Related]

  • 45. Selective suppression of hepatic glucose output by human proinsulin in the dog.
    Lavelle-Jones M, Scott MH, Kolterman O, Rubenstein AH, Olefsky JM, Moossa AR.
    Am J Physiol; 1987 Feb; 252(2 Pt 1):E230-6. PubMed ID: 2881485
    [Abstract] [Full Text] [Related]

  • 46. Exercise-induced rise in glucagon and ketogenesis during prolonged muscular work.
    Wasserman DH, Spalding JA, Bracy D, Lacy DB, Cherrington AD.
    Diabetes; 1989 Jun; 38(6):799-807. PubMed ID: 2566546
    [Abstract] [Full Text] [Related]

  • 47. The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog.
    Sindelar DK, Chu CA, Rohlie M, Neal DW, Swift LL, Cherrington AD.
    Diabetes; 1997 Feb; 46(2):187-96. PubMed ID: 9000693
    [Abstract] [Full Text] [Related]

  • 48. Effect of epinephrine on glycogenolysis and gluconeogenesis in conscious overnight-fasted dogs.
    Cherrington AD, Fuchs H, Stevenson RW, Williams PE, Alberti KG, Steiner KE.
    Am J Physiol; 1984 Aug; 247(2 Pt 1):E137-44. PubMed ID: 6380303
    [Abstract] [Full Text] [Related]

  • 49. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE, Lorenzi M, Bier DM, Tsalikian E, Schneider V, Karam JH, Forsham PH.
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [Abstract] [Full Text] [Related]

  • 50. Somatostatin does not alter insulin-mediated glucose disposal.
    Meneilly GS, Elahi D, Minaker KL, Rowe JW.
    J Clin Endocrinol Metab; 1987 Aug; 65(2):364-7. PubMed ID: 2885337
    [Abstract] [Full Text] [Related]

  • 51. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
    Baron AD, Schaeffer L, Shragg P, Kolterman OG.
    Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757
    [Abstract] [Full Text] [Related]

  • 52. Interactions of glucagon and free fatty acids with insulin in control of glucose metabolism.
    Chambrier C, Picard S, Vidal H, Cohen R, Riou JP, Beylot M.
    Metabolism; 1990 Sep; 39(9):976-84. PubMed ID: 1975421
    [Abstract] [Full Text] [Related]

  • 53. Excessive glucose production, rather than insulin resistance, accounts for hyperglycaemia in recent-onset streptozotocin-diabetic rats.
    Burcelin R, Eddouks M, Maury J, Kande J, Assan R, Girard J.
    Diabetologia; 1995 Mar; 38(3):283-90. PubMed ID: 7758874
    [Abstract] [Full Text] [Related]

  • 54. Altered ability of the liver to produce glucose following a period of glucagon deficiency.
    Deri JJ, Williams PE, Steiner KE, Cherrington AD.
    Diabetes; 1981 Jun; 30(6):490-5. PubMed ID: 6112181
    [Abstract] [Full Text] [Related]

  • 55. Glucoregulation in alloxan-diabetic dogs.
    Lussier B, Vranic M, Kovacevic N, Hetenyi G.
    Metabolism; 1986 Jan; 35(1):18-24. PubMed ID: 3510360
    [Abstract] [Full Text] [Related]

  • 56. Lack of effect of somatostatin on epinephrine-stimulated glucose production in the dog.
    Stevenson RW, Steiner KE, Williams PE, Cherrington AD.
    Metabolism; 1987 May; 36(5):451-7. PubMed ID: 2883556
    [Abstract] [Full Text] [Related]

  • 57. Assessment of hepatic sensitivity to glucagon in NIDDM: use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesis.
    Nielsen MF, Wise S, Dinneen SF, Schwenk WF, Basu A, Rizza RA.
    Diabetes; 1997 Dec; 46(12):2007-16. PubMed ID: 9392488
    [Abstract] [Full Text] [Related]

  • 58. Influence of somatostatin on glucagon- and epinephrine-stimulated hepatic glucose output in the dog.
    Saccà L, Sherwin R, Felig P.
    Am J Physiol; 1979 Feb; 236(2):E113-7. PubMed ID: 420283
    [Abstract] [Full Text] [Related]

  • 59. Importance of basal glucagon in maintaining hepatic glucose production during a prolonged fast in conscious dogs.
    Hendrick GK, Wasserman DH, Frizzell RT, Williams PE, Lacy DB, Jaspan JB, Cherrington AD.
    Am J Physiol; 1992 Sep; 263(3 Pt 1):E541-9. PubMed ID: 1415534
    [Abstract] [Full Text] [Related]

  • 60. The effect of pioglitazone on hepatic glucose uptake measured with indirect and direct methods in alloxan-induced diabetic dogs.
    Matsuhisa M, Shi ZQ, Wan C, Lekas M, Rodgers CD, Giacca A, Kawamori R, Vranic M.
    Diabetes; 1997 Feb; 46(2):224-31. PubMed ID: 9000698
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.